Stephen R. Marder, MD | Psychiatrist.com

Original Research

The Texas Medication Algorithm Project Antipsychotic Algorithm for Schizophrenia: 2003 Update

April 1, 2004

Alexander L. Miller, Catherine S. Hall, Robert W. Buchanan, et al

Academic Highlights

New Developments in Antipsychotic Therapy.

November 15, 2003

Peter J. Weiden, W. Wolfgang Fleischhacker, John M. Kane, et al

Article

Overview of Partial Compliance

November 1, 2003

Stephen R. Marder

Article

Clinical Guidelines: Dosing and Switching Strategies for Long-Acting Risperidone

November 1, 2003

Stephen R. Marder, Robert Conley, Larry Ereshefsky, et al

Article

Evidence for Using Atypical Antipsychotics in Psychosis

March 1, 2003

Stephen R. Marder

Letter to the Editor

Olanzapine Treatment for Patients With Schizophrenia and Cocaine Abuse

December 1, 2002

John Tsuang, Stephen R. Marder, Amanda Han, et al

Academic Highlights

Using Atypical Antipsychotics in Primary Care

December 1, 2002

Joseph A. Liberman III, Sally Berry, Larry Culpepper, et al

Original Research

Risperidone, 2 mg/day vs. 4 mg/day, in First-Episode, Acutely Psychotic Patients: Treatment Efficacy and Effects on Fine Motor Functioning

October 1, 2002

Marco C. G. Merlo, Helene Hofer, Walter Gekle, et al

Original Research

The Effects of Novel Antipsychotics on Glucose and Lipid Levels

October 1, 2002

Donna A. Wirshing, Jennifer A. Boyd, Laura R. Meng, et al

Book Review

Schizophrenia Revealed: From Neurons to Social Interactions

June 18, 2002

Stephen R. Marder

Original Research

Clinical Predictors of Response to Clozapine Treatment in Ambulatory Patients With Schizophrenia

May 12, 2002

Daniel S. Umbricht, William C. Wirshing, Donna A. Wirshing, et al

Original Research

Novel Antipsychotics: Comparison of Weight Gain Liabilities

June 30, 1999

Donna A. Wirshing, William C. Wirshing, Lisa Kysar, et al

« 1 2 3 4 »